CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $28.06M, above the global median of $16.24M
- PositionOperating margin is 31%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations7 currently firing — 1 · 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
8.05%Below 5Y avg (10.42%)
Annual Rate
SGD 0.06Paid quarterly
Payout Ratio
69.7%Moderate
Last Ex-Dividend
May 7, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
High Dividend Payout With FCF And Equity Ratio
→dividend payout intensity
fcf positive 3y
ratio balance equity
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
High Dividend Payout With FCF And Equity Ratio
It pays out most of its earnings, on three years of positive free cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.25BSGD978.51M · vs all stocks (USD)
Trailing P/E
20.63xvs Medical Instruments & Supplies peers
Revenue (TTM)
307.72MSGD241.85M · vs all stocks (USD)
Profit Margin
21.74%vs Medical Instruments & Supplies peers
Beta
0.7640xvs all stocks
52-Week Change
14.18%vs all stocks
Forward Annual Dividend Yield
8.05%vs all stocks
Market Capitalization
1.25BSGD978.51M · vs all stocks (USD)
Enterprise Value
203.64MSGD160.05M · vs all stocks (USD)
Trailing P/E
20.63xvs Medical Instruments & Supplies peers
Forward P/E
15.81xvs Medical Instruments & Supplies peers
PEG Ratio
-0.8950xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.25xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.65xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.6620xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
1.94xvs Medical Instruments & Supplies peers
Gross Margin
29.61%vs Medical Instruments & Supplies peers
Profit Margin
21.74%vs Medical Instruments & Supplies peers
Operating Margin
30.95%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
10.12%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
14.68%vs Medical Instruments & Supplies peers
Revenue (TTM)
307.72MSGD241.85M · vs all stocks (USD)
Revenue per Share (TTM)
0.6610SGDUpdated Aug 21, 2026Quarterly Revenue Growth
8.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
97.08MSGD76.30M · vs all stocks (USD)
Net Income (TTM)
66.89MSGD52.57M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
45.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
81.12MSGD63.76M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
35.70MSGD28.06M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0648SGDUpdated Aug 21, 2026Forward Annual Dividend Yield
8.05%vs all stocks
Trailing Annual Dividend Rate
0.0447SGDUpdated Aug 21, 2026Trailing Annual Dividend Yield
5.55%vs all stocks
5-Year Average Dividend Yield
10.42%vs all stocks
Payout Ratio
69.67%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
3.00KMYRFY2025 · Dec 31, 2025Revenue
995.31MMYRFY2025 · Dec 31, 2025Cost of Goods Sold
696.63MMYRFY2025 · Dec 31, 2025Gross Profit
298.69MMYRFY2025 · Dec 31, 2025Operating Income
244.11MMYR60.35M · vs all stocks (USD)
Pre-tax Income
264.48MMYRFY2025 · Dec 31, 2025Income Tax Expense
56.70MMYRFY2025 · Dec 31, 2025Net Income
207.77MMYRFY2025 · Dec 31, 2025EBIT
264.50MMYRFY2025 · Dec 31, 2025EBITDA (Income Statement)
335.97MMYRFY2025 · Dec 31, 2025Selling, General & Administrative
49.97MMYRFY2025 · Dec 31, 2025Other Operating Expenses
4.61MMYRFY2025 · Dec 31, 2025Non-operating Interest Expense
20.00KMYRFY2025 · Dec 31, 2025EPS (Basic)
0.1402MYRFY2025 · Dec 31, 2025EPS (Diluted)
0.1402MYRFY2025 · Dec 31, 2025Basic Shares Outstanding
1.48BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.48BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00MYRFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00MYRFY2025 · Dec 31, 2025Operating Cash Flow
275.51MMYRFY2025 · Dec 31, 2025Free Cash Flow
194.34MMYRFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
630.35MMYRFY2025 · Dec 31, 2025Starting Profit (CF Statement)
264.48MMYRFY2025 · Dec 31, 2025Other Non-cash Items
-18.12MMYRFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
18.24MMYRFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
10.91MMYRFY2025 · Dec 31, 2025Capital Expenditures
-81.17MMYRFY2025 · Dec 31, 2025Net Investing Cash Flow
-81.17MMYRFY2025 · Dec 31, 2025Common Dividends Paid
-296.43MMYRFY2025 · Dec 31, 2025Net Financing Cash Flow
-296.43MMYRFY2025 · Dec 31, 2025Shares Outstanding
1.48BSharesUpdated Aug 21, 2026Float Shares
520.67MSharesUpdated Aug 21, 2026% Held by Insiders
64.75%vs all stocks
% Held by Institutions
13.33%vs all stocks
Total Cash (MRQ)
181.02MSGD142.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3890SGDUpdated Aug 21, 2026Total Debt (MRQ)
369.58KSGD290.47K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0008xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
7.78xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.3114SGDUpdated Aug 21, 2026Total Assets
1.64BMYR405.38M · vs all stocks (USD)
Total Current Assets
888.33MMYRFY2025 · Dec 31, 2025Total Liabilities
163.92MMYRFY2025 · Dec 31, 2025Total Non-current Assets
751.30MMYRFY2025 · Dec 31, 2025Total Non-current Liabilities
67.65MMYRFY2025 · Dec 31, 2025Total Current Liabilities
96.27MMYRFY2025 · Dec 31, 2025Cash & Cash Equivalents
630.35MMYRFY2025 · Dec 31, 2025Accounts Receivable
162.84MMYRFY2025 · Dec 31, 2025Inventory
87.33MMYRFY2025 · Dec 31, 2025Accounts Payable
86.76MMYRFY2025 · Dec 31, 2025Short-term Debt
0.00MYRFY2025 · Dec 31, 2025Common Stock (Book)
156.34MMYRFY2025 · Dec 31, 2025Retained Earnings
1.37BMYRFY2025 · Dec 31, 2025Total Shareholders' Equity
1.48BMYR364.85M · vs all stocks (USD)
Treasury Stock
815.00KMYRFY2025 · Dec 31, 202552-Week Low
0.6650SGDUpdated Aug 21, 202652-Week High
0.9850SGDUpdated Aug 21, 202652-Week Change
14.18%vs all stocks
Beta
0.7640xvs all stocks
50-Day MA
0.8478SGDUpdated Aug 21, 2026200-Day MA
0.8224SGDUpdated Aug 21, 2026Avg 10-Day Volume
2.40MSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.34MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.0400SGDUpdated Aug 21, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 31%, higher than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: 0.31Industry median: 0.12Industry P95: 0.27Peers compared: 65.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.78
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $28.06M, above the global median of $16.24MNotable
Levered free cash flow (USD): 28,055,040.776Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hangzhou MDK OptoElectronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Suzhou Huazhijie Telecom Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shin-Etsu Polymer Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Suqian Unitech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fujian Nebula Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Tianma Intelligent Control Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Huangshan Novel Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Coship Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guizhou Tyre Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Henan Hengxing Science Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Guangdong Lingxiao Pump Co., Ltd.
7 interpretationsHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedRetained Earnings Heavy With Elevated Payout
P-Duke Technology Co., Ltd.
7 interpretationsHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedRetained Earnings Heavy With Elevated Payout
Foshan Haitian Flavouring & Food Co., Ltd.
6 interpretationsHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedRetained Earnings Heavy With Elevated Payout